Annual D&A
$1.99 M
-$6.16 M-75.59%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual depreciation & amortization is $1.99 million, with the most recent change of -$6.16 million (-75.59%) on December 31, 2023.
- During the last 3 years, RDHL annual D&A has fallen by -$6.75 million (-77.24%).
- RDHL annual D&A is now -89.04% below its all-time high of $18.15 million, reached on December 31, 2021.
Performance
RDHL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
June 1, 2024
Summary
- RDHL quarterly depreciation & amortization is not available.
Performance
RDHL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
June 1, 2024
Summary
- RDHL TTM depreciation & amortization is not available.
Performance
RDHL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
RDHL Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -75.6% | - | - |
| 3 y3 years | -77.2% | - | - |
| 5 y5 years | +2111.1% | - | - |
RDHL Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.0% | at low | ||||
| 5 y | 5-year | -89.0% | +64.1% | ||||
| alltime | all time | -89.0% | -100.0% |
RedHill Biopharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $1.99 M(-75.6%) | - | - |
| Jun 2023 | - | -$58.90 M(-197.4%) | $5.68 M(-91.5%) |
| Mar 2023 | - | $60.48 M(+2912.2%) | $66.50 M(+715.6%) |
| Dec 2022 | $8.15 M(-55.1%) | $2.01 M(-4.0%) | $8.15 M(-53.0%) |
| Sep 2022 | - | $2.09 M(+9.2%) | $17.34 M(-1.4%) |
| Jun 2022 | - | $1.92 M(-10.4%) | $17.59 M(-2.1%) |
| Mar 2022 | - | $2.14 M(-80.9%) | $17.97 M(-1.0%) |
| Dec 2021 | $18.15 M(+107.5%) | $11.19 M(+377.9%) | $18.15 M(+90.9%) |
| Sep 2021 | - | $2.34 M(+2.0%) | $9.51 M(-2.4%) |
| Jun 2021 | - | $2.29 M(-1.0%) | $9.74 M(+1.1%) |
| Mar 2021 | - | $2.32 M(-9.1%) | $9.64 M(+10.2%) |
| Dec 2020 | $8.74 M(+620.9%) | $2.55 M(-1.1%) | $8.74 M(+31.2%) |
| Sep 2020 | - | $2.58 M(+17.8%) | $6.66 M(+52.4%) |
| Jun 2020 | - | $2.19 M(+53.6%) | $4.37 M(+81.6%) |
| Mar 2020 | - | $1.43 M(+204.1%) | $2.41 M(+98.5%) |
| Dec 2019 | $1.21 M(+1247.8%) | $469.00 K(+62.8%) | $1.21 M(+58.1%) |
| Sep 2019 | - | $288.00 K(+28.0%) | $767.00 K(+53.1%) |
| Jun 2019 | - | $225.00 K(-2.6%) | $501.00 K(+67.6%) |
| Mar 2019 | - | $231.00 K(+904.3%) | $299.00 K(+232.2%) |
| Dec 2018 | $90.00 K(+11.1%) | $23.00 K(+4.5%) | $90.00 K(0.0%) |
| Sep 2018 | - | $22.00 K(-4.3%) | $90.00 K(-4.3%) |
| Jun 2018 | - | $23.00 K(+4.5%) | $94.00 K(+5.6%) |
| Mar 2018 | - | $22.00 K(-4.3%) | $89.00 K(+9.9%) |
| Dec 2017 | $81.00 K | $23.00 K(-11.5%) | $81.00 K(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $26.00 K(+44.4%) | $70.00 K(+27.3%) |
| Jun 2017 | - | $18.00 K(+28.6%) | $55.00 K(+14.6%) |
| Mar 2017 | - | $14.00 K(+16.7%) | $48.00 K(+9.1%) |
| Dec 2016 | $44.00 K(+22.2%) | $12.00 K(+9.1%) | $44.00 K(+4.8%) |
| Sep 2016 | - | $11.00 K(0.0%) | $42.00 K(+5.0%) |
| Jun 2016 | - | $11.00 K(+10.0%) | $40.00 K(+8.1%) |
| Mar 2016 | - | $10.00 K(0.0%) | $37.00 K(+2.8%) |
| Dec 2015 | $36.00 K(+33.3%) | $10.00 K(+11.1%) | $36.00 K(+5.9%) |
| Sep 2015 | - | $9000.00(+12.5%) | $34.00 K(+9.7%) |
| Jun 2015 | - | $8000.00(-11.1%) | $31.00 K(+6.9%) |
| Mar 2015 | - | $9000.00(+12.5%) | $29.00 K(+7.4%) |
| Dec 2014 | $27.00 K(+12.5%) | $8000.00(+33.3%) | $27.00 K(+8.0%) |
| Sep 2014 | - | $6000.00(0.0%) | $25.00 K(-3.8%) |
| Jun 2014 | - | $6000.00(-14.3%) | $26.00 K(+4.0%) |
| Mar 2014 | - | $7000.00(+16.7%) | $25.00 K(+4.2%) |
| Dec 2013 | $24.00 K(0.0%) | $6000.00(-14.3%) | $24.00 K(-11.1%) |
| Sep 2013 | - | $7000.00(+40.0%) | $27.00 K(+12.5%) |
| Jun 2013 | - | $5000.00(-16.7%) | $24.00 K(+4.3%) |
| Mar 2013 | - | $6000.00(-33.3%) | $23.00 K(-4.2%) |
| Dec 2012 | $24.00 K(+60.0%) | $9000.00(+125.0%) | $24.00 K(+60.0%) |
| Sep 2012 | - | $4000.00(0.0%) | $15.00 K(+36.4%) |
| Jun 2012 | - | $4000.00(-42.9%) | $11.00 K(+57.1%) |
| Mar 2012 | - | $7000.00 | $7000.00 |
| Dec 2011 | $15.00 K(>+9900.0%) | - | - |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is RedHill Biopharma annual depreciation & amortization?
- What is the all time high annual D&A for RedHill Biopharma?
- What is RedHill Biopharma annual D&A year-on-year change?
- What is the all time high quarterly D&A for RedHill Biopharma?
- What is the all time high TTM D&A for RedHill Biopharma?
What is RedHill Biopharma annual depreciation & amortization?
The current annual D&A of RDHL is $1.99 M
What is the all time high annual D&A for RedHill Biopharma?
RedHill Biopharma all-time high annual depreciation & amortization is $18.15 M
What is RedHill Biopharma annual D&A year-on-year change?
Over the past year, RDHL annual depreciation & amortization has changed by -$6.16 M (-75.59%)
What is the all time high quarterly D&A for RedHill Biopharma?
RedHill Biopharma all-time high quarterly depreciation & amortization is $60.48 M
What is the all time high TTM D&A for RedHill Biopharma?
RedHill Biopharma all-time high TTM depreciation & amortization is $66.50 M